Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
LYNWOOD CAPITAL MANAGEMENT INC | 02-14-2024 | 12-31-2023 | 56 | 22,712,922,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
BRIACELL THERAPEUTICS CORP | COM NEW | Liquidated | $0 | 0 | 26.01 | 12.88 | -1,428 | -0.09 | 12-31-2023 |
BRIACELL THERAPEUTICS CORP | COM | 2 | $9,246,773,000 | 1,580,645 | 40.71 | 1,580,645 | +Inf | 12-31-2023 | |
AMERICAS GOLD AND SILVER COR | COM | 3 | $2,438,113,000 | 9,800,000 | 10.73 | 9.53 | -351,000 | -3.46 | 12-31-2023 |
TARGET GLOBAL ACQUISI I CORP | CLASS A ORD SHS | Liquidated | $0 | 0 | 3.96 | 1.87 | 0 | 0.00 | 12-31-2023 |